Earlier this week, the FDA announced that it is issuing a nationwide voluntary recall of two EpiPen products. These are Mylan’s EpiPen and also the EpiPen Jr. Such epinephrine auto-injectors are used as emergency treatments for severe allergic reactions.
The recall is being carried out by Meridian Medical Technologies. This latter is also the producer of the respective products. It will be looking to recover items from 13 lots, all distributed by Mylan Specialty. In its announcements, the FDA also presented the reason behind the recall.
According to the health authority, it reached this decision after noticing that these EpiPen products may potentially contain a defective part. Because of it, the auto-injectors may fail to activate, which could lead to even bigger issues.
A Recalled EpiPen Products List Is Available On Mylan’s Page
The FDA states that the number of reported failures is quite small. However, the defective products carry quite a life-threatening risk. This is especially higher in cases of severe allergic reactions that might remain untreated because of them.
Consumers should check their EpiPen and EpiPen Jr. products and see if they fit the recall description. They can check the lot numbers and codes by accessing this Mylan page.
In case the codes fit, they should contact Mylan by email or through a phone call, especially if they have any questions. Users should keep their EpiPen products and use them in case of need up until they get a replacement. This will be offered for free after the consumers contact Stericycle.
The device label itself points out that consumers should seek emergency medical attention after using the auto-injector. They should also immediately do so, especially if the product did not activate.
Users who do not find their auto-injector on the recall list do not have to replace their products before the expiration date. In case of device malfunctions or adverse reactions, users can access the MedWatch program carried out by the FDA.
Image Source: Wikimedia